SCHEMBL9018638

SCHEMBL9018638

O=C(O)O[C@H]1C[C@@H]2CCC[C@@H]2N1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.38
CHRM4 P08173 5/20 0.38
CHRM3 P20309 5/20 0.38
CHRM1 P11229 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10348710 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL11023496 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL3161056 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL10588845 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL11206299 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL9574615 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL10816002 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL10813888 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL10651393 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1
SCHEMBL10587624 1.00 CHRM2 (0.38) CHRM2CHRM4CHRM3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044010-B1 NEW PHARMACEUTICAL INTERMEDIATES IN THE SYNTHESIS OF ACE-INIHIBITORS AND THE USE THEREOF EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDO RESZVENYTARSASAG (HU) 2014-01-08 EP claimed
EP-0344572-A2 Composition of angiotensin-converting-enzyme inhibitor with calcium chanell modulators and uses thereof as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1989-12-06 EP claimed
EP-0338508-A2 Esters from amino-acids, their preparation process, drugs containing same and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-10-25 EP claimed
EP-0720988-A1 Pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane BAYER AG (DE) 1996-07-10 EP disclosed
EP-0720987-A1 Acylated pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane BAYER AG (DE) 1996-07-10 EP disclosed
EP-0297620-B1 Process for the preparation of byciclic aminocarboxylic acids, intermediates for this process and their use HOECHST AG (DE) 1994-11-30 EP disclosed
EP-0338508-A2 Esters from amino-acids, their preparation process, drugs containing same and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-10-25 EP disclosed
EP-0331609-A2 Angiotensin converting enzyme inhibitors having psychotropic effects HOECHST AKTIENGESELLSCHAFT (DE) 1989-09-06 EP disclosed
EP-0326974-A1 Amino acid amides with a psychotropic activity, processes for their preparation, compositions containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-09 EP disclosed
EP-0325160-A2 Amino-acid glycerides, process for their preparation, medicaments containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-07-26 EP disclosed
EP-0317878-A1 Stabilized pharmaceutical agents, process for preparing them, and stable pharmaceutical preparations HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-31 EP disclosed
EP-0297620-A2 Process for the preparation of byciclic aminocarboxylic acids, intermediates for this process and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-04 EP disclosed
EP-0214570-A2 N-alkylated tripeptides, process for their preparation, medicaments containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-18 EP disclosed